Trade Names:
Synonyms:
Status: Approved (2002)
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 4Q52C550XK

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lymphoma, Follicular 3 D008224 ClinicalTrials
Lymphoma, Non-Hodgkin 3 D008228 ClinicalTrials
Lymphoma, Follicular 3 D008224 ClinicalTrials
Lymphoma 2 D008223 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Blood and lymphatic system disorders
18.87
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.51
General disorders and administration site conditions
7.99
Investigations
7.6
Respiratory, thoracic and mediastinal disorders
6.82
Infections and infestations
6.29
Skin and subcutaneous tissue disorders
5.9
Gastrointestinal disorders
5.24
Injury, poisoning and procedural complications
5.11
Vascular disorders
3.67
Nervous system disorders
2.62
Reproductive system and breast disorders
2.62
Hepatobiliary disorders
2.1

Cross References

Resources Reference
CAS NUMBER 206181-63-7
ChEMBL CHEMBL1201606
FDA SRS 4Q52C550XK
Guide to Pharmacology 6777
PubChem 74890578